Berkeley, CA · Founded 2016 · Privately Held (backing)
Developer of a bioprinting technology designed to recreate and engineer human tissues in vitro. Prellis Biologics is based in Berkeley, CA and was founded in 2016. It was valued at $110 million at its later-stage round in Nov 2023, the last priced event on record. It has raised $70.2 million across 5 recorded rounds; the latest was a $17 million early-stage round in Jun 2022.
PMV mark · valuation
$110.1M
Oct 2026
Priced at
its later-stage round
Nov 2023
Total raised
$70.2M
Last round
Early Stage VC
Jun 2022
No prints on record
No secondary trades in Prellis Biologics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Prellis Biologics with a free account
·The complete investor list: 16 names
·Watch Prellis Biologics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Prellis Biologics stock.
